nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Zonisamide—epilepsy syndrome	0.212	0.313	CbGbCtD
Pyrazinamide—CYP1A2—Carbamazepine—epilepsy syndrome	0.0323	0.0476	CbGbCtD
Pyrazinamide—CYP1A2—Primidone—epilepsy syndrome	0.0301	0.0445	CbGbCtD
Pyrazinamide—CYP1A2—Propofol—epilepsy syndrome	0.027	0.0398	CbGbCtD
Pyrazinamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0269	0.0397	CbGbCtD
Pyrazinamide—CYP1A2—Phenobarbital—epilepsy syndrome	0.0258	0.0381	CbGbCtD
Pyrazinamide—CYP3A4—Trimethadione—epilepsy syndrome	0.025	0.0369	CbGbCtD
Pyrazinamide—CYP3A4—Felbamate—epilepsy syndrome	0.025	0.0369	CbGbCtD
Pyrazinamide—CYP1A2—Diazepam—epilepsy syndrome	0.0245	0.0361	CbGbCtD
Pyrazinamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0235	0.0347	CbGbCtD
Pyrazinamide—CYP3A4—Clonazepam—epilepsy syndrome	0.0213	0.0314	CbGbCtD
Pyrazinamide—CYP3A4—Clobazam—epilepsy syndrome	0.0204	0.0301	CbGbCtD
Pyrazinamide—CYP1A2—Valproic Acid—epilepsy syndrome	0.0193	0.0285	CbGbCtD
Pyrazinamide—CYP3A4—Rufinamide—epilepsy syndrome	0.0174	0.0256	CbGbCtD
Pyrazinamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0169	0.025	CbGbCtD
Pyrazinamide—CYP3A4—Primidone—epilepsy syndrome	0.0158	0.0233	CbGbCtD
Pyrazinamide—CYP3A4—Phenytoin—epilepsy syndrome	0.0152	0.0224	CbGbCtD
Pyrazinamide—CYP3A4—Propofol—epilepsy syndrome	0.0142	0.0209	CbGbCtD
Pyrazinamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0135	0.02	CbGbCtD
Pyrazinamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0135	0.02	CbGbCtD
Pyrazinamide—CYP3A4—Midazolam—epilepsy syndrome	0.0133	0.0197	CbGbCtD
Pyrazinamide—CYP3A4—Diazepam—epilepsy syndrome	0.0128	0.0189	CbGbCtD
Pyrazinamide—CYP3A4—Zonisamide—epilepsy syndrome	0.0125	0.0185	CbGbCtD
Pyrazinamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0101	0.0149	CbGbCtD
Pyrazinamide—CYP3A4—Topiramate—epilepsy syndrome	0.00912	0.0135	CbGbCtD
Pyrazinamide—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000328	0.00162	CcSEcCtD
Pyrazinamide—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000327	0.00161	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000326	0.00161	CcSEcCtD
Pyrazinamide—Urticaria—Propofol—epilepsy syndrome	0.000326	0.00161	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Gabapentin—epilepsy syndrome	0.000325	0.00161	CcSEcCtD
Pyrazinamide—Vomiting—Lacosamide—epilepsy syndrome	0.000325	0.0016	CcSEcCtD
Pyrazinamide—Body temperature increased—Propofol—epilepsy syndrome	0.000324	0.0016	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000324	0.0016	CcSEcCtD
Pyrazinamide—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000324	0.0016	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000324	0.0016	CcSEcCtD
Pyrazinamide—Dyspepsia—Diazepam—epilepsy syndrome	0.000323	0.0016	CcSEcCtD
Pyrazinamide—Nausea—Rufinamide—epilepsy syndrome	0.000323	0.0016	CcSEcCtD
Pyrazinamide—Rash—Lacosamide—epilepsy syndrome	0.000322	0.00159	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000322	0.00159	CcSEcCtD
Pyrazinamide—Dermatitis—Lacosamide—epilepsy syndrome	0.000322	0.00159	CcSEcCtD
Pyrazinamide—Arthralgia—Lamotrigine—epilepsy syndrome	0.00032	0.00158	CcSEcCtD
Pyrazinamide—Myalgia—Lamotrigine—epilepsy syndrome	0.00032	0.00158	CcSEcCtD
Pyrazinamide—Anorexia—Clonazepam—epilepsy syndrome	0.000319	0.00158	CcSEcCtD
Pyrazinamide—Decreased appetite—Diazepam—epilepsy syndrome	0.000319	0.00158	CcSEcCtD
Pyrazinamide—Urticaria—Midazolam—epilepsy syndrome	0.000319	0.00158	CcSEcCtD
Pyrazinamide—Anorexia—Phenytoin—epilepsy syndrome	0.000317	0.00157	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000317	0.00157	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000317	0.00157	CcSEcCtD
Pyrazinamide—Discomfort—Lamotrigine—epilepsy syndrome	0.000317	0.00156	CcSEcCtD
Pyrazinamide—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000316	0.00156	CcSEcCtD
Pyrazinamide—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000315	0.00156	CcSEcCtD
Pyrazinamide—Vomiting—Clobazam—epilepsy syndrome	0.000315	0.00156	CcSEcCtD
Pyrazinamide—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000313	0.00155	CcSEcCtD
Pyrazinamide—Dyspepsia—Felbamate—epilepsy syndrome	0.000313	0.00155	CcSEcCtD
Pyrazinamide—Rash—Clobazam—epilepsy syndrome	0.000312	0.00154	CcSEcCtD
Pyrazinamide—Dermatitis—Clobazam—epilepsy syndrome	0.000312	0.00154	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000311	0.00154	CcSEcCtD
Pyrazinamide—Hepatitis—Pregabalin—epilepsy syndrome	0.000311	0.00154	CcSEcCtD
Pyrazinamide—Decreased appetite—Felbamate—epilepsy syndrome	0.000309	0.00153	CcSEcCtD
Pyrazinamide—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000307	0.00152	CcSEcCtD
Pyrazinamide—Dyspepsia—Zonisamide—epilepsy syndrome	0.000306	0.00151	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000305	0.00151	CcSEcCtD
Pyrazinamide—Urticaria—Fosphenytoin—epilepsy syndrome	0.000304	0.0015	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000303	0.0015	CcSEcCtD
Pyrazinamide—Nausea—Lacosamide—epilepsy syndrome	0.000303	0.0015	CcSEcCtD
Pyrazinamide—Anorexia—Carbamazepine—epilepsy syndrome	0.000303	0.0015	CcSEcCtD
Pyrazinamide—Feeling abnormal—Diazepam—epilepsy syndrome	0.000303	0.0015	CcSEcCtD
Pyrazinamide—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000302	0.00149	CcSEcCtD
Pyrazinamide—Decreased appetite—Zonisamide—epilepsy syndrome	0.000302	0.00149	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000302	0.00149	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000301	0.00149	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.0003	0.00148	CcSEcCtD
Pyrazinamide—Urticaria—Vigabatrin—epilepsy syndrome	0.000296	0.00146	CcSEcCtD
Pyrazinamide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000296	0.00146	CcSEcCtD
Pyrazinamide—Dyspepsia—Clonazepam—epilepsy syndrome	0.000295	0.00146	CcSEcCtD
Pyrazinamide—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000295	0.00146	CcSEcCtD
Pyrazinamide—Nausea—Clobazam—epilepsy syndrome	0.000294	0.00146	CcSEcCtD
Pyrazinamide—Dyspepsia—Phenytoin—epilepsy syndrome	0.000293	0.00145	CcSEcCtD
Pyrazinamide—Feeling abnormal—Felbamate—epilepsy syndrome	0.000293	0.00145	CcSEcCtD
Pyrazinamide—Anorexia—Lamotrigine—epilepsy syndrome	0.000293	0.00145	CcSEcCtD
Pyrazinamide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000292	0.00144	CcSEcCtD
Pyrazinamide—Urticaria—Diazepam—epilepsy syndrome	0.000292	0.00144	CcSEcCtD
Pyrazinamide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000292	0.00144	CcSEcCtD
Pyrazinamide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000291	0.00144	CcSEcCtD
Pyrazinamide—Pruritus—Propofol—epilepsy syndrome	0.00029	0.00143	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.00029	0.00143	CcSEcCtD
Pyrazinamide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000289	0.00143	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000289	0.00143	CcSEcCtD
Pyrazinamide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000288	0.00142	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000287	0.00142	CcSEcCtD
Pyrazinamide—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000287	0.00142	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000286	0.00141	CcSEcCtD
Pyrazinamide—Hepatitis—Gabapentin—epilepsy syndrome	0.000285	0.00141	CcSEcCtD
Pyrazinamide—Pruritus—Midazolam—epilepsy syndrome	0.000284	0.0014	CcSEcCtD
Pyrazinamide—Urticaria—Felbamate—epilepsy syndrome	0.000282	0.0014	CcSEcCtD
Pyrazinamide—Body temperature increased—Felbamate—epilepsy syndrome	0.000281	0.00139	CcSEcCtD
Pyrazinamide—Vomiting—Acetazolamide—epilepsy syndrome	0.000281	0.00139	CcSEcCtD
Pyrazinamide—Pruritus—Levetiracetam—epilepsy syndrome	0.00028	0.00139	CcSEcCtD
Pyrazinamide—Dysuria—Topiramate—epilepsy syndrome	0.00028	0.00138	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.00028	0.00138	CcSEcCtD
Pyrazinamide—Dyspepsia—Carbamazepine—epilepsy syndrome	0.00028	0.00138	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Valproic Acid—epilepsy syndrome	0.000277	0.00137	CcSEcCtD
Pyrazinamide—Urticaria—Zonisamide—epilepsy syndrome	0.000276	0.00137	CcSEcCtD
Pyrazinamide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000276	0.00137	CcSEcCtD
Pyrazinamide—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000276	0.00137	CcSEcCtD
Pyrazinamide—Body temperature increased—Zonisamide—epilepsy syndrome	0.000275	0.00136	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000275	0.00136	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000274	0.00136	CcSEcCtD
Pyrazinamide—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000274	0.00136	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000273	0.00135	CcSEcCtD
Pyrazinamide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000273	0.00135	CcSEcCtD
Pyrazinamide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000271	0.00134	CcSEcCtD
Pyrazinamide—Hypersensitivity—Diazepam—epilepsy syndrome	0.00027	0.00134	CcSEcCtD
Pyrazinamide—Dyspepsia—Lamotrigine—epilepsy syndrome	0.00027	0.00134	CcSEcCtD
Pyrazinamide—Malaise—Valproic Acid—epilepsy syndrome	0.00027	0.00133	CcSEcCtD
Pyrazinamide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000267	0.00132	CcSEcCtD
Pyrazinamide—Urticaria—Clonazepam—epilepsy syndrome	0.000266	0.00132	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000265	0.00131	CcSEcCtD
Pyrazinamide—Body temperature increased—Clonazepam—epilepsy syndrome	0.000265	0.00131	CcSEcCtD
Pyrazinamide—Urticaria—Phenytoin—epilepsy syndrome	0.000264	0.00131	CcSEcCtD
Pyrazinamide—Pruritus—Vigabatrin—epilepsy syndrome	0.000264	0.0013	CcSEcCtD
Pyrazinamide—Body temperature increased—Phenytoin—epilepsy syndrome	0.000263	0.0013	CcSEcCtD
Pyrazinamide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000263	0.0013	CcSEcCtD
Pyrazinamide—Nausea—Acetazolamide—epilepsy syndrome	0.000262	0.0013	CcSEcCtD
Pyrazinamide—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000262	0.00129	CcSEcCtD
Pyrazinamide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000262	0.00129	CcSEcCtD
Pyrazinamide—Vomiting—Propofol—epilepsy syndrome	0.000261	0.00129	CcSEcCtD
Pyrazinamide—Pruritus—Diazepam—epilepsy syndrome	0.00026	0.00128	CcSEcCtD
Pyrazinamide—Rash—Propofol—epilepsy syndrome	0.000259	0.00128	CcSEcCtD
Pyrazinamide—Dermatitis—Propofol—epilepsy syndrome	0.000258	0.00128	CcSEcCtD
Pyrazinamide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000256	0.00127	CcSEcCtD
Pyrazinamide—Vomiting—Midazolam—epilepsy syndrome	0.000255	0.00126	CcSEcCtD
Pyrazinamide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000255	0.00126	CcSEcCtD
Pyrazinamide—Myalgia—Valproic Acid—epilepsy syndrome	0.000255	0.00126	CcSEcCtD
Pyrazinamide—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000253	0.00125	CcSEcCtD
Pyrazinamide—Rash—Midazolam—epilepsy syndrome	0.000253	0.00125	CcSEcCtD
Pyrazinamide—Dermatitis—Midazolam—epilepsy syndrome	0.000253	0.00125	CcSEcCtD
Pyrazinamide—Urticaria—Carbamazepine—epilepsy syndrome	0.000252	0.00125	CcSEcCtD
Pyrazinamide—Vomiting—Levetiracetam—epilepsy syndrome	0.000252	0.00125	CcSEcCtD
Pyrazinamide—Discomfort—Valproic Acid—epilepsy syndrome	0.000252	0.00124	CcSEcCtD
Pyrazinamide—Pruritus—Felbamate—epilepsy syndrome	0.000251	0.00124	CcSEcCtD
Pyrazinamide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000251	0.00124	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000251	0.00124	CcSEcCtD
Pyrazinamide—Rash—Levetiracetam—epilepsy syndrome	0.00025	0.00124	CcSEcCtD
Pyrazinamide—Dermatitis—Levetiracetam—epilepsy syndrome	0.00025	0.00123	CcSEcCtD
Pyrazinamide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000247	0.00122	CcSEcCtD
Pyrazinamide—Pruritus—Zonisamide—epilepsy syndrome	0.000246	0.00122	CcSEcCtD
Pyrazinamide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000245	0.00121	CcSEcCtD
Pyrazinamide—Urticaria—Lamotrigine—epilepsy syndrome	0.000244	0.00121	CcSEcCtD
Pyrazinamide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000244	0.00121	CcSEcCtD
Pyrazinamide—Malaise—Pregabalin—epilepsy syndrome	0.000244	0.00121	CcSEcCtD
Pyrazinamide—Nausea—Propofol—epilepsy syndrome	0.000244	0.0012	CcSEcCtD
Pyrazinamide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000243	0.0012	CcSEcCtD
Pyrazinamide—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000243	0.0012	CcSEcCtD
Pyrazinamide—Rash—Fosphenytoin—epilepsy syndrome	0.000241	0.00119	CcSEcCtD
Pyrazinamide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000241	0.00119	CcSEcCtD
Pyrazinamide—Hepatitis—Topiramate—epilepsy syndrome	0.00024	0.00118	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000239	0.00118	CcSEcCtD
Pyrazinamide—Nausea—Midazolam—epilepsy syndrome	0.000238	0.00118	CcSEcCtD
Pyrazinamide—Pruritus—Clonazepam—epilepsy syndrome	0.000237	0.00117	CcSEcCtD
Pyrazinamide—Vomiting—Vigabatrin—epilepsy syndrome	0.000237	0.00117	CcSEcCtD
Pyrazinamide—Pruritus—Phenytoin—epilepsy syndrome	0.000236	0.00116	CcSEcCtD
Pyrazinamide—Nausea—Levetiracetam—epilepsy syndrome	0.000235	0.00116	CcSEcCtD
Pyrazinamide—Rash—Vigabatrin—epilepsy syndrome	0.000235	0.00116	CcSEcCtD
Pyrazinamide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000235	0.00116	CcSEcCtD
Pyrazinamide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000234	0.00116	CcSEcCtD
Pyrazinamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000234	0.00116	CcSEcCtD
Pyrazinamide—Vomiting—Diazepam—epilepsy syndrome	0.000233	0.00115	CcSEcCtD
Pyrazinamide—Anorexia—Valproic Acid—epilepsy syndrome	0.000233	0.00115	CcSEcCtD
Pyrazinamide—Rash—Diazepam—epilepsy syndrome	0.000231	0.00114	CcSEcCtD
Pyrazinamide—Dermatitis—Diazepam—epilepsy syndrome	0.000231	0.00114	CcSEcCtD
Pyrazinamide—Myalgia—Pregabalin—epilepsy syndrome	0.00023	0.00114	CcSEcCtD
Pyrazinamide—Arthralgia—Pregabalin—epilepsy syndrome	0.00023	0.00114	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.00023	0.00114	CcSEcCtD
Pyrazinamide—Discomfort—Pregabalin—epilepsy syndrome	0.000227	0.00112	CcSEcCtD
Pyrazinamide—Nausea—Fosphenytoin—epilepsy syndrome	0.000227	0.00112	CcSEcCtD
Pyrazinamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000226	0.00112	CcSEcCtD
Pyrazinamide—Vomiting—Felbamate—epilepsy syndrome	0.000226	0.00112	CcSEcCtD
Pyrazinamide—Pruritus—Carbamazepine—epilepsy syndrome	0.000225	0.00111	CcSEcCtD
Pyrazinamide—Rash—Felbamate—epilepsy syndrome	0.000224	0.00111	CcSEcCtD
Pyrazinamide—Dermatitis—Felbamate—epilepsy syndrome	0.000224	0.00111	CcSEcCtD
Pyrazinamide—Malaise—Gabapentin—epilepsy syndrome	0.000224	0.00111	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000222	0.0011	CcSEcCtD
Pyrazinamide—Nausea—Vigabatrin—epilepsy syndrome	0.000221	0.00109	CcSEcCtD
Pyrazinamide—Vomiting—Zonisamide—epilepsy syndrome	0.000221	0.00109	CcSEcCtD
Pyrazinamide—Rash—Zonisamide—epilepsy syndrome	0.000219	0.00108	CcSEcCtD
Pyrazinamide—Dermatitis—Zonisamide—epilepsy syndrome	0.000219	0.00108	CcSEcCtD
Pyrazinamide—Nausea—Diazepam—epilepsy syndrome	0.000218	0.00108	CcSEcCtD
Pyrazinamide—Pruritus—Lamotrigine—epilepsy syndrome	0.000217	0.00107	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000216	0.00107	CcSEcCtD
Pyrazinamide—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000215	0.00106	CcSEcCtD
Pyrazinamide—Vomiting—Clonazepam—epilepsy syndrome	0.000213	0.00105	CcSEcCtD
Pyrazinamide—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000212	0.00105	CcSEcCtD
Pyrazinamide—Vomiting—Phenytoin—epilepsy syndrome	0.000212	0.00105	CcSEcCtD
Pyrazinamide—Rash—Clonazepam—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Dermatitis—Clonazepam—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Arthralgia—Gabapentin—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Myalgia—Gabapentin—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Nausea—Felbamate—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000211	0.00104	CcSEcCtD
Pyrazinamide—Anorexia—Pregabalin—epilepsy syndrome	0.00021	0.00104	CcSEcCtD
Pyrazinamide—Rash—Phenytoin—epilepsy syndrome	0.00021	0.00104	CcSEcCtD
Pyrazinamide—Dermatitis—Phenytoin—epilepsy syndrome	0.00021	0.00104	CcSEcCtD
Pyrazinamide—Rash—Oxcarbazepine—epilepsy syndrome	0.000209	0.00103	CcSEcCtD
Pyrazinamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000209	0.00103	CcSEcCtD
Pyrazinamide—Discomfort—Gabapentin—epilepsy syndrome	0.000209	0.00103	CcSEcCtD
Pyrazinamide—Nausea—Zonisamide—epilepsy syndrome	0.000207	0.00102	CcSEcCtD
Pyrazinamide—Vomiting—Carbamazepine—epilepsy syndrome	0.000202	0.000999	CcSEcCtD
Pyrazinamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000201	0.000994	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000201	0.000994	CcSEcCtD
Pyrazinamide—Rash—Carbamazepine—epilepsy syndrome	0.0002	0.000991	CcSEcCtD
Pyrazinamide—Dermatitis—Carbamazepine—epilepsy syndrome	0.0002	0.00099	CcSEcCtD
Pyrazinamide—Nausea—Clonazepam—epilepsy syndrome	0.000199	0.000984	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000198	0.000979	CcSEcCtD
Pyrazinamide—Nausea—Phenytoin—epilepsy syndrome	0.000198	0.000978	CcSEcCtD
Pyrazinamide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000197	0.000972	CcSEcCtD
Pyrazinamide—Vomiting—Lamotrigine—epilepsy syndrome	0.000195	0.000965	CcSEcCtD
Pyrazinamide—Urticaria—Valproic Acid—epilepsy syndrome	0.000194	0.000958	CcSEcCtD
Pyrazinamide—Rash—Lamotrigine—epilepsy syndrome	0.000194	0.000957	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000194	0.000957	CcSEcCtD
Pyrazinamide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000193	0.000956	CcSEcCtD
Pyrazinamide—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000193	0.000954	CcSEcCtD
Pyrazinamide—Anorexia—Gabapentin—epilepsy syndrome	0.000193	0.000953	CcSEcCtD
Pyrazinamide—Decreased appetite—Pregabalin—epilepsy syndrome	0.000192	0.000948	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.00019	0.000942	CcSEcCtD
Pyrazinamide—Nausea—Carbamazepine—epilepsy syndrome	0.000189	0.000933	CcSEcCtD
Pyrazinamide—Malaise—Topiramate—epilepsy syndrome	0.000188	0.00093	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000184	0.000911	CcSEcCtD
Pyrazinamide—Nausea—Lamotrigine—epilepsy syndrome	0.000182	0.000902	CcSEcCtD
Pyrazinamide—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000182	0.000899	CcSEcCtD
Pyrazinamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00018	0.000889	CcSEcCtD
Pyrazinamide—Dyspepsia—Gabapentin—epilepsy syndrome	0.000178	0.00088	CcSEcCtD
Pyrazinamide—Myalgia—Topiramate—epilepsy syndrome	0.000178	0.000878	CcSEcCtD
Pyrazinamide—Arthralgia—Topiramate—epilepsy syndrome	0.000178	0.000878	CcSEcCtD
Pyrazinamide—Decreased appetite—Gabapentin—epilepsy syndrome	0.000176	0.000869	CcSEcCtD
Pyrazinamide—Discomfort—Topiramate—epilepsy syndrome	0.000175	0.000867	CcSEcCtD
Pyrazinamide—Urticaria—Pregabalin—epilepsy syndrome	0.000175	0.000867	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000175	0.000863	CcSEcCtD
Pyrazinamide—Body temperature increased—Pregabalin—epilepsy syndrome	0.000174	0.000862	CcSEcCtD
Pyrazinamide—Pruritus—Valproic Acid—epilepsy syndrome	0.000173	0.000854	CcSEcCtD
Pyrazinamide—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000167	0.000824	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000167	0.000824	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000163	0.000804	CcSEcCtD
Pyrazinamide—Anorexia—Topiramate—epilepsy syndrome	0.000162	0.000802	CcSEcCtD
Pyrazinamide—Urticaria—Gabapentin—epilepsy syndrome	0.000161	0.000795	CcSEcCtD
Pyrazinamide—Body temperature increased—Gabapentin—epilepsy syndrome	0.00016	0.000791	CcSEcCtD
Pyrazinamide—Pruritus—Pregabalin—epilepsy syndrome	0.000156	0.000772	CcSEcCtD
Pyrazinamide—Vomiting—Valproic Acid—epilepsy syndrome	0.000155	0.000767	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000155	0.000767	CcSEcCtD
Pyrazinamide—Rash—Valproic Acid—epilepsy syndrome	0.000154	0.000761	CcSEcCtD
Pyrazinamide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000154	0.00076	CcSEcCtD
Pyrazinamide—Dyspepsia—Topiramate—epilepsy syndrome	0.00015	0.000741	CcSEcCtD
Pyrazinamide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000149	0.000737	CcSEcCtD
Pyrazinamide—Decreased appetite—Topiramate—epilepsy syndrome	0.000148	0.000731	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000147	0.000726	CcSEcCtD
Pyrazinamide—Nausea—Valproic Acid—epilepsy syndrome	0.000145	0.000717	CcSEcCtD
Pyrazinamide—Pruritus—Gabapentin—epilepsy syndrome	0.000143	0.000708	CcSEcCtD
Pyrazinamide—Vomiting—Pregabalin—epilepsy syndrome	0.00014	0.000694	CcSEcCtD
Pyrazinamide—Feeling abnormal—Topiramate—epilepsy syndrome	0.00014	0.000693	CcSEcCtD
Pyrazinamide—Rash—Pregabalin—epilepsy syndrome	0.000139	0.000688	CcSEcCtD
Pyrazinamide—Dermatitis—Pregabalin—epilepsy syndrome	0.000139	0.000687	CcSEcCtD
Pyrazinamide—Urticaria—Topiramate—epilepsy syndrome	0.000135	0.000668	CcSEcCtD
Pyrazinamide—Body temperature increased—Topiramate—epilepsy syndrome	0.000135	0.000665	CcSEcCtD
Pyrazinamide—Nausea—Pregabalin—epilepsy syndrome	0.000131	0.000648	CcSEcCtD
Pyrazinamide—Vomiting—Gabapentin—epilepsy syndrome	0.000129	0.000636	CcSEcCtD
Pyrazinamide—Rash—Gabapentin—epilepsy syndrome	0.000128	0.000631	CcSEcCtD
Pyrazinamide—Dermatitis—Gabapentin—epilepsy syndrome	0.000127	0.00063	CcSEcCtD
Pyrazinamide—Hypersensitivity—Topiramate—epilepsy syndrome	0.000125	0.00062	CcSEcCtD
Pyrazinamide—Pruritus—Topiramate—epilepsy syndrome	0.00012	0.000595	CcSEcCtD
Pyrazinamide—Nausea—Gabapentin—epilepsy syndrome	0.00012	0.000594	CcSEcCtD
Pyrazinamide—Vomiting—Topiramate—epilepsy syndrome	0.000108	0.000535	CcSEcCtD
Pyrazinamide—Rash—Topiramate—epilepsy syndrome	0.000107	0.000531	CcSEcCtD
Pyrazinamide—Dermatitis—Topiramate—epilepsy syndrome	0.000107	0.00053	CcSEcCtD
Pyrazinamide—Nausea—Topiramate—epilepsy syndrome	0.000101	0.0005	CcSEcCtD
Pyrazinamide—AOX1—Metabolism—NT5E—epilepsy syndrome	8.26e-05	0.00069	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ASAH1—epilepsy syndrome	8.1e-05	0.000676	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	7.92e-05	0.000661	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	7.88e-05	0.000658	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALDH7A1—epilepsy syndrome	7.88e-05	0.000658	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—STXBP1—epilepsy syndrome	7.88e-05	0.000658	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CACNA1A—epilepsy syndrome	7.88e-05	0.000658	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	7.84e-05	0.000654	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ST3GAL3—epilepsy syndrome	7.71e-05	0.000644	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NT5E—epilepsy syndrome	7.68e-05	0.000641	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALAD—epilepsy syndrome	7.68e-05	0.000641	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ADSL—epilepsy syndrome	7.56e-05	0.000631	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GLUL—epilepsy syndrome	7.41e-05	0.000619	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CACNA1A—epilepsy syndrome	7.33e-05	0.000612	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALDH7A1—epilepsy syndrome	7.33e-05	0.000612	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CACNA1D—epilepsy syndrome	7.28e-05	0.000607	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ST3GAL3—epilepsy syndrome	7.17e-05	0.000599	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.07e-05	0.00059	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ADSL—epilepsy syndrome	7.03e-05	0.000586	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GLUL—epilepsy syndrome	6.89e-05	0.000575	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TXNRD1—epilepsy syndrome	6.8e-05	0.000568	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CACNA1D—epilepsy syndrome	6.76e-05	0.000564	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EIF2AK2—epilepsy syndrome	6.71e-05	0.00056	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AQP1—epilepsy syndrome	6.61e-05	0.000551	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TXNRD1—epilepsy syndrome	6.33e-05	0.000528	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.32e-05	0.000527	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.32e-05	0.000527	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PPIA—epilepsy syndrome	6.21e-05	0.000518	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AQP1—epilepsy syndrome	6.14e-05	0.000513	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CHRM3—epilepsy syndrome	5.97e-05	0.000499	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—KCNJ11—epilepsy syndrome	5.97e-05	0.000499	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	5.62e-05	0.000469	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CHRM3—epilepsy syndrome	5.55e-05	0.000464	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—KCNJ11—epilepsy syndrome	5.55e-05	0.000464	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.54e-05	0.000462	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	5.46e-05	0.000456	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	5.43e-05	0.000453	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	5.39e-05	0.00045	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.35e-05	0.000447	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.32e-05	0.000444	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	5.11e-05	0.000427	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	5.08e-05	0.000424	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	4.93e-05	0.000411	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCG2—epilepsy syndrome	4.87e-05	0.000406	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	4.87e-05	0.000406	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.8e-05	0.000401	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.79e-05	0.0004	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2C19—epilepsy syndrome	4.75e-05	0.000396	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP11A1—epilepsy syndrome	4.72e-05	0.000394	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SLC2A1—epilepsy syndrome	4.6e-05	0.000384	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—JUNB—epilepsy syndrome	4.56e-05	0.000381	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS1—epilepsy syndrome	4.53e-05	0.000378	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCG2—epilepsy syndrome	4.53e-05	0.000378	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.49e-05	0.000375	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	4.42e-05	0.000369	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.42e-05	0.000369	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2C19—epilepsy syndrome	4.41e-05	0.000368	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP11A1—epilepsy syndrome	4.39e-05	0.000366	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.38e-05	0.000365	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HBEGF—epilepsy syndrome	4.32e-05	0.000361	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	4.3e-05	0.000359	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.27e-05	0.000357	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2D6—epilepsy syndrome	4.26e-05	0.000355	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT3—epilepsy syndrome	4.24e-05	0.000354	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.21e-05	0.000352	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.19e-05	0.00035	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.16e-05	0.000347	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ADAM10—epilepsy syndrome	4.14e-05	0.000346	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.13e-05	0.000345	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.11e-05	0.000343	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ADRA2A—epilepsy syndrome	4.05e-05	0.000338	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—BCHE—epilepsy syndrome	4.04e-05	0.000337	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2D6—epilepsy syndrome	3.96e-05	0.00033	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDC42—epilepsy syndrome	3.87e-05	0.000323	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SLC2A1—epilepsy syndrome	3.85e-05	0.000321	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.83e-05	0.000319	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PLCB1—epilepsy syndrome	3.81e-05	0.000318	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TH—epilepsy syndrome	3.79e-05	0.000317	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ADRA2A—epilepsy syndrome	3.77e-05	0.000314	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.76e-05	0.000314	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—BCHE—epilepsy syndrome	3.75e-05	0.000313	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA13—epilepsy syndrome	3.71e-05	0.00031	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.7e-05	0.000309	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	3.69e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	3.69e-05	0.000308	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SLC2A1—epilepsy syndrome	3.58e-05	0.000299	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HES1—epilepsy syndrome	3.54e-05	0.000296	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLCB1—epilepsy syndrome	3.54e-05	0.000295	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TH—epilepsy syndrome	3.53e-05	0.000294	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.46e-05	0.000289	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FYN—epilepsy syndrome	3.45e-05	0.000288	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—H2AFX—epilepsy syndrome	3.43e-05	0.000287	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—YWHAZ—epilepsy syndrome	3.31e-05	0.000276	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CCR5—epilepsy syndrome	3.19e-05	0.000266	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMOX1—epilepsy syndrome	3.17e-05	0.000264	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAT—epilepsy syndrome	3.12e-05	0.000261	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCB1—epilepsy syndrome	3.04e-05	0.000254	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.99e-05	0.000249	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TSC2—epilepsy syndrome	2.96e-05	0.000247	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—epilepsy syndrome	2.94e-05	0.000246	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAT—epilepsy syndrome	2.9e-05	0.000242	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOE—epilepsy syndrome	2.9e-05	0.000242	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.86e-05	0.000239	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCB1—epilepsy syndrome	2.83e-05	0.000236	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPX1—epilepsy syndrome	2.83e-05	0.000236	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PDXK—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FAR1—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CERS1—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADK—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	2.81e-05	0.000235	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6ST—epilepsy syndrome	2.72e-05	0.000227	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS2—epilepsy syndrome	2.7e-05	0.000225	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPX1—epilepsy syndrome	2.63e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GAMT—epilepsy syndrome	2.57e-05	0.000215	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	2.57e-05	0.000215	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PNPO—epilepsy syndrome	2.57e-05	0.000215	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	2.57e-05	0.000215	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AGT—epilepsy syndrome	2.48e-05	0.000207	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOE—epilepsy syndrome	2.43e-05	0.000203	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA4—epilepsy syndrome	2.39e-05	0.0002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—QDPR—epilepsy syndrome	2.39e-05	0.0002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	2.38e-05	0.000199	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AGT—epilepsy syndrome	2.3e-05	0.000192	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—epilepsy syndrome	2.26e-05	0.000188	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COX3—epilepsy syndrome	2.25e-05	0.000188	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF2—epilepsy syndrome	2.2e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.17e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	2.13e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	2.13e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PFKL—epilepsy syndrome	2.13e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	2.13e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	2.13e-05	0.000178	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—POMC—epilepsy syndrome	2.09e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.08e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.07e-05	0.000173	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTOR—epilepsy syndrome	2e-05	0.000167	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—epilepsy syndrome	1.99e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.99e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.99e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.99e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.99e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.95e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.95e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.95e-05	0.000163	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—POMC—epilepsy syndrome	1.94e-05	0.000162	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—epilepsy syndrome	1.9e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.88e-05	0.000157	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.85e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.85e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.84e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.81e-05	0.000151	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.81e-05	0.000151	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.77e-05	0.000148	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—epilepsy syndrome	1.77e-05	0.000148	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.74e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.7e-05	0.000142	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—epilepsy syndrome	1.66e-05	0.000139	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.66e-05	0.000138	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.65e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.65e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.65e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.65e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.65e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.62e-05	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.62e-05	0.000135	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SRC—epilepsy syndrome	1.61e-05	0.000134	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—epilepsy syndrome	1.55e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.54e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.54e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.51e-05	0.000126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.5e-05	0.000126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.5e-05	0.000126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.5e-05	0.000126	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.48e-05	0.000123	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.45e-05	0.000121	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.45e-05	0.000121	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.42e-05	0.000119	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.4e-05	0.000117	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.4e-05	0.000117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.33e-05	0.000111	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.32e-05	0.00011	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.29e-05	0.000108	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.28e-05	0.000107	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.25e-05	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.25e-05	0.000104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.24e-05	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.19e-05	9.93e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.19e-05	9.93e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.17e-05	9.75e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.17e-05	9.75e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-05	9.72e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.14e-05	9.52e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.12e-05	9.34e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.1e-05	9.16e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.09e-05	9.08e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.07e-05	8.9e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.03e-05	8.57e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—epilepsy syndrome	9.98e-06	8.33e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.97e-06	8.32e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	9.52e-06	7.95e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	9.28e-06	7.75e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	9.22e-06	7.7e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.16e-06	7.64e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.02e-06	7.52e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.02e-06	7.52e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—epilepsy syndrome	8.36e-06	6.98e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.35e-06	6.97e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	8.32e-06	6.95e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.92e-06	6.61e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.89e-06	6.59e-05	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—epilepsy syndrome	7.77e-06	6.49e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.53e-06	6.28e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.45e-06	6.21e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TH—epilepsy syndrome	7.42e-06	6.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.35e-06	6.13e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.3e-06	6.1e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.16e-06	5.98e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.12e-06	5.94e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.42e-06	5.36e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.19e-06	5.17e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.12e-06	5.1e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.11e-06	5.1e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.09e-06	5.08e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.94e-06	4.96e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.81e-06	4.85e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.75e-06	4.8e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TH—epilepsy syndrome	5.73e-06	4.78e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.53e-06	4.61e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.84e-06	4.04e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.78e-06	3.99e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.75e-06	3.96e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.72e-06	3.94e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.59e-06	3.83e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.26e-06	3.56e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.08e-06	3.4e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.74e-06	3.12e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.72e-06	3.1e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.66e-06	3.06e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.25e-06	2.71e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.15e-06	2.63e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.87e-06	2.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.51e-06	2.1e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.63e-06	1.36e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
